Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)

SHE:002603 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,040	853.03	940.51	1,904	995.26	1,337
Trading Asset Securities	560.5	-	205.97	518.38	55.27	216.97
Cash & Short-Term Investments	1,601	853.03	1,146	2,423	1,051	1,554
Cash Growth	30.80%	-25.60%	-52.68%	130.61%	-32.40%	51.44%
Accounts Receivable	1,956	1,390	2,596	2,178	2,361	1,756
Other Receivables	17.77	130.07	5.59	6.54	4.73	18.27
Receivables	1,974	1,520	2,602	2,184	2,366	1,775
Inventory	1,468	1,746	2,459	2,022	1,673	1,580
Prepaid Expenses	5.53	26.09	93.9	0.7	39.39	37.04
Other Current Assets	120	189.28	242.67	624.8	473.65	513.54
Total Current Assets	5,168	4,335	6,544	7,254	5,602	5,459
Property, Plant & Equipment	7,095	7,253	7,311	6,229	5,758	4,313
Long-Term Investments	5.54	3.47	1,651	1,349	1	1
Goodwill	106.39	109.51	115.75	-	-	-
Other Intangible Assets	792.47	802.57	743.52	724.01	660.5	480.41
Long-Term Deferred Tax Assets	307.48	365.84	183.58	284.43	117	137.77
Long-Term Deferred Charges	301.83	266.88	189.37	107.16	239.33	261.17
Other Long-Term Assets	123.18	183.39	241.39	392.65	527.03	839.62
Total Assets	13,899	13,319	16,979	16,341	12,905	11,492
Accounts Payable	1,766	1,897	2,847	2,061	1,621	1,188
Accrued Expenses	274.88	350.83	419.64	644.78	269.71	306.97
Short-Term Debt	-	-	600.35	500.35	702.48	270.18
Current Portion of Long-Term Debt	-	-	201.12	150.12	-	-
Current Portion of Leases	9.75	8.24	5.5	5.86	13.43	-
Current Income Taxes Payable	24.32	23.46	42.45	242.15	11.38	59.4
Current Unearned Revenue	409.21	272.34	287.52	1,106	301.56	354.74
Other Current Liabilities	41.85	55.26	43.58	140.35	40.7	59.21
Total Current Liabilities	2,526	2,607	4,447	4,850	2,960	2,239
Long-Term Debt	-	-	599.1	200.15	500.47	-
Long-Term Leases	21.8	18.21	13.01	14.97	12.53	-
Long-Term Unearned Revenue	371.48	377.92	352.37	335.02	357.84	328.09
Long-Term Deferred Tax Liabilities	112.39	114.25	130.14	10.24	1.39	2.02
Total Liabilities	3,032	3,117	5,541	5,411	3,833	2,569
Common Stock	1,671	1,671	1,671	1,671	1,671	1,204
Additional Paid-In Capital	2,324	2,343	2,343	2,343	2,343	2,932
Retained Earnings	6,886	6,217	7,443	6,926	5,065	4,915
Treasury Stock	-	-	-	-	-	-122.15
Comprehensive Income & Other	-7.24	-7.12	-6.61	-7.22	-9.71	-9.08
Total Common Equity	10,873	10,223	11,450	10,932	9,069	8,919
Minority Interest	-5.69	-21.4	-11.73	-1.95	3.04	4.09
Shareholders' Equity	10,867	10,202	11,438	10,930	9,072	8,923
Total Liabilities & Equity	13,899	13,319	16,979	16,341	12,905	11,492
Total Debt	31.54	26.45	1,419	871.45	1,229	270.18
Net Cash (Debt)	1,569	826.58	-272.6	1,551	-178.37	1,284
Net Cash Growth	-	-	-	-	-	31.52%
Net Cash Per Share	0.94	0.49	-0.16	0.93	-0.11	0.77
Filing Date Shares Outstanding	1,671	1,671	1,671	1,671	1,671	1,667
Total Common Shares Outstanding	1,671	1,671	1,671	1,671	1,671	1,667
Working Capital	2,642	1,728	2,097	2,404	2,642	3,221
Book Value Per Share	6.51	6.12	6.85	6.54	5.43	5.35
Tangible Book Value	9,974	9,311	10,590	10,208	8,409	8,439
Tangible Book Value Per Share	5.97	5.57	6.34	6.11	5.03	5.06
Buildings	5,675	5,668	5,407	4,353	3,620	2,997
Machinery	3,601	3,581	3,098	2,484	2,005	1,499
Construction In Progress	1,281	1,197	1,471	1,574	1,950	1,371

Source: S&P Global Market Intelligence. Standard template. Financial Sources.